{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:28:54Z","timestamp":1790072934850,"version":"4.0.1"},"reference-count":24,"publisher":"Portland Press Ltd.","issue":"8","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Ischemic heart disease (IHD) represents the leading cause of morbidity and mortality worldwide. Therapy options generally aim at restoring the blood flow to the heart muscle and relieve the ischemic insult. Paradoxically, coronary artery reperfusion itself, both during emergency intervention in ST segment elevation myocardial infarction (STEMI) patients or in the setting of elective cardiac surgery, damages the heart muscle, a phenomenon known as myocardial ischemia-reperfusion (I\/R) injury (IRI). Ischemic preconditioning (IPC) is defined by episodes of \u2018sub-lethal\u2019 ischemia and reperfusion prior to prolonged coronary artery occlusion. It has been extensively studied as a promising approach to attenuate IRI, but two recent multicenter clinical trials of remote IPC (RIPC) on clinical outcomes have been disappointing. Macrophage migration-inhibitory factor (MIF) is a structurally unique chemokine-like inflammatory cytokine. MIF is pro-atherogenic, but has a complex function in the ischemic heart with a surprising potential as a local cardioprotective factor in early myocardial ischemia. A recent paper published in Clinical Science by Ruze et al. [9], now suggests that MIF could be a key player mediating IPC in the ischemic heart. Employing a Mif gene knockout mouse model, the study indicates a role for endogenous MIF in IPC-mediated protection from myocardial IRI. It could assist in understanding how this atypical cytokine controls ischemic heart pathologies and may set the stage for novel MIF-based therapeutic strategies in IHD.<\/jats:p>","DOI":"10.1042\/cs20190036","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T12:55:14Z","timestamp":1555592114000},"page":"933-937","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Protective cardiac conditioning by an atypical cytokine"],"prefix":"10.1042","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2996-2652","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Bernhagen","sequence":"first","affiliation":[{"name":"Chair of Vascular Biology, Institute for Stroke and Dementia Research (ISD), Klinikum der Universit\u00e4t M\u00fcnchen (KUM), Ludwig-Maximilians-University (LMU), Munich 81377, Germany"},{"name":"Munich Heart Alliance, Munich 80802, Germany"},{"name":"Munich Cluster for Systems Neurology (SyNergy), Munich 81377, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2019,4,18]]},"reference":[{"key":"2021113012285775100_B1","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1161\/CIRCULATIONAHA.113.004046","article-title":"The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study","volume":"129","author":"Moran","year":"2014","journal-title":"Circulation"},{"key":"2021113012285775100_B2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(18)30423-9","article-title":"Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data","volume":"391","author":"Head","year":"2018","journal-title":"Lancet"},{"key":"2021113012285775100_B3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J. Clin. Invest."},{"key":"2021113012285775100_B4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","article-title":"Ischaemic conditioning and reperfusion injury","volume":"13","author":"Hausenloy","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"2021113012285775100_B5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","article-title":"Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium","volume":"74","author":"Murry","year":"1986","journal-title":"Circulation"},{"key":"2021113012285775100_B6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/CIRCRESAHA.116.305462","article-title":"The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs","volume":"116","author":"Jones","year":"2015","journal-title":"Circ. Res."},{"key":"2021113012285775100_B7","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1413534","article-title":"Remote ischemic preconditioning and outcomes of cardiac surgery","volume":"373","author":"Hausenloy","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2021113012285775100_B8","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa1413579","article-title":"A multicenter trial of remote ischemic preconditioning for heart surgery","volume":"373","author":"Meybohm","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2021113012285775100_B9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1042\/CS20181013","article-title":"Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection","volume":"133","author":"Ruze","year":"2019","journal-title":"Clin. Sci."},{"key":"2021113012285775100_B10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1073\/pnas.56.1.72","article-title":"Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction","volume":"56","author":"David","year":"1966","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113012285775100_B11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: a regulator of innate immunity","volume":"3","author":"Calandra","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"2021113012285775100_B12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/cvr\/cvu071","article-title":"Macrophage migration inhibitory factor in myocardial ischaemia\/reperfusion injury","volume":"102","author":"Rassaf","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"2021113012285775100_B13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/14728222.2017.1336227","article-title":"MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics","volume":"21","author":"Tilstam","year":"2017","journal-title":"Exp. Opin. Ther. Targets"},{"key":"2021113012285775100_B14","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1161\/CIRCULATIONAHA.111.069104","article-title":"Cardioprotection through S-nitros(yl)ation of macrophage migration inhibitory factor","volume":"125","author":"Luedike","year":"2012","journal-title":"Circulation"},{"key":"2021113012285775100_B15","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nature06504","article-title":"Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart","volume":"451","author":"Miller","year":"2008","journal-title":"Nature"},{"key":"2021113012285775100_B16","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1172\/JCI39738","article-title":"Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia\/reperfusion","volume":"119","author":"Qi","year":"2009","journal-title":"J. Clin. Invest."},{"key":"2021113012285775100_B17","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1089\/ars.2010.3163","article-title":"Macrophage migration inhibitory factor provides cardioprotection during ischemia\/reperfusion by reducing oxidative stress","volume":"14","author":"Koga","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"2021113012285775100_B18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/CIRCULATIONAHA.112.000862","article-title":"Limiting cardiac ischemic injury by pharmacological augmentation of macrophage migration inhibitory factor-AMP-activated protein kinase signal transduction","volume":"128","author":"Wang","year":"2013","journal-title":"Circulation"},{"key":"2021113012285775100_B19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.yjmcc.2010.12.022","article-title":"Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation","volume":"50","author":"Gao","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"key":"2021113012285775100_B20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1042\/CS20130828","article-title":"Role of MIF in myocardial ischaemia and infarction: insight from recent clinical and experimental findings","volume":"127","author":"Dayawansa","year":"2014","journal-title":"Clin. Sci."},{"key":"2021113012285775100_B21","first-page":"208","article-title":"Admission macrophage migration inhibitory factor predicts long-term prognosis in patients with ST-elevation myocardial infarction","volume":"4","author":"Deng","year":"2018","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"2021113012285775100_B22","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.jacc.2015.02.026","article-title":"Plasma exosomes protect the myocardium from ischemia-reperfusion injury","volume":"65","author":"Vicencio","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113012285775100_B23","doi-asserted-by":"publisher","first-page":"e92827","DOI":"10.1371\/journal.pone.0092827","article-title":"The role of macrophage migration inhibitory factor in anesthetic-induced myocardial preconditioning","volume":"9","author":"Goetzenich","year":"2014","journal-title":"PLoS ONE"},{"key":"2021113012285775100_B24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10557-016-6673-2","article-title":"Exogenous administration of recombinant MIF at physiological concentrations failed to attenuate infarct size in a Langendorff perfused isolated mouse heart model","volume":"30","author":"Rossello","year":"2016","journal-title":"Cardiovasc. Drugs Ther."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/133\/8\/933\/843521\/cs-2019-0036c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/133\/8\/933\/843521\/cs-2019-0036c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T12:31:40Z","timestamp":1638275500000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/133\/8\/933\/218851\/Protective-cardiac-conditioning-by-an-atypical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,4,30]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20190036","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4]]},"published":{"date-parts":[[2019,4]]}}}